JP2010529081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010529081A5 JP2010529081A5 JP2010510783A JP2010510783A JP2010529081A5 JP 2010529081 A5 JP2010529081 A5 JP 2010529081A5 JP 2010510783 A JP2010510783 A JP 2010510783A JP 2010510783 A JP2010510783 A JP 2010510783A JP 2010529081 A5 JP2010529081 A5 JP 2010529081A5
- Authority
- JP
- Japan
- Prior art keywords
- difluorophenyl
- ethylpyrrolidin
- pyrrolidin
- fluorophenyl
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 7
- 150000001204 N-oxides Chemical class 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- LJSQUPHAOKTMIR-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=CC(F)=C1F LJSQUPHAOKTMIR-UHFFFAOYSA-N 0.000 claims 3
- NCIWSEVOPAYAFW-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(F)C(F)=C1 NCIWSEVOPAYAFW-UHFFFAOYSA-N 0.000 claims 3
- LFOPWHXMDFGBCZ-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(F)C(F)=C1 LFOPWHXMDFGBCZ-UHFFFAOYSA-N 0.000 claims 3
- PZCIZLSHEPXHAY-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC(F)=CC(F)=C1 PZCIZLSHEPXHAY-UHFFFAOYSA-N 0.000 claims 3
- SJBRVYCKTOKPMU-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC(F)=CC(F)=C1 SJBRVYCKTOKPMU-UHFFFAOYSA-N 0.000 claims 3
- ZCCVFEZXNYDPFH-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC(F)=CC(F)=C1 ZCCVFEZXNYDPFH-UHFFFAOYSA-N 0.000 claims 3
- VUYBUSQWWQWBAX-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=CC(Cl)=C1F VUYBUSQWWQWBAX-UHFFFAOYSA-N 0.000 claims 3
- ZNMYFXMWLGTUBE-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=CC(Cl)=C1F ZNMYFXMWLGTUBE-UHFFFAOYSA-N 0.000 claims 3
- NIGZAKLAUVDBKT-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC(F)=CC(Cl)=C1 NIGZAKLAUVDBKT-UHFFFAOYSA-N 0.000 claims 3
- XYFCSWGDPHKZKM-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC(F)=CC(Cl)=C1 XYFCSWGDPHKZKM-UHFFFAOYSA-N 0.000 claims 3
- 208000010877 cognitive disease Diseases 0.000 claims 3
- 201000000980 schizophrenia Diseases 0.000 claims 3
- QDFWOUONMZLLJG-UHFFFAOYSA-N 1-(cyclopropylmethyl)-3-(2,3-difluorophenyl)pyrrolidin-3-ol Chemical compound C1C(O)(C=2C(=C(F)C=CC=2)F)CCN1CC1CC1 QDFWOUONMZLLJG-UHFFFAOYSA-N 0.000 claims 2
- UEBPNMSACCRKBW-UHFFFAOYSA-N 1-butyl-3-(2,3-difluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=CC(F)=C1F UEBPNMSACCRKBW-UHFFFAOYSA-N 0.000 claims 2
- KYLAQLWJVQYHFE-UHFFFAOYSA-N 1-butyl-3-(3,5-difluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC(F)=CC(F)=C1 KYLAQLWJVQYHFE-UHFFFAOYSA-N 0.000 claims 2
- WGXFCVDUBAPUSV-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=CC(F)=C1F WGXFCVDUBAPUSV-UHFFFAOYSA-N 0.000 claims 2
- NHQBQIQRZDBVFY-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=CC(F)=C1F NHQBQIQRZDBVFY-UHFFFAOYSA-N 0.000 claims 2
- JSQSGEOUGAKKCB-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-(3,3,3-trifluoropropyl)pyrrolidin-3-ol Chemical compound C=1C=CC(F)=C(F)C=1C1(O)CCN(CCC(F)(F)F)C1 JSQSGEOUGAKKCB-UHFFFAOYSA-N 0.000 claims 2
- XYBMKKZXZVSIEC-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=CC(F)=C1F XYBMKKZXZVSIEC-UHFFFAOYSA-N 0.000 claims 2
- NCYIYMVGKMWQLA-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=CC(F)=C1F NCYIYMVGKMWQLA-UHFFFAOYSA-N 0.000 claims 2
- CCJZNYJTLCONPI-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC(F)=CC(F)=C1 CCJZNYJTLCONPI-UHFFFAOYSA-N 0.000 claims 2
- SYUUBVPTDUWJOY-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC(F)=CC(F)=C1 SYUUBVPTDUWJOY-UHFFFAOYSA-N 0.000 claims 2
- PYDSFTRKWFHUTI-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-prop-2-enylpyrrolidin-3-ol Chemical compound C=1C(F)=CC(F)=CC=1C1(O)CCN(CC=C)C1 PYDSFTRKWFHUTI-UHFFFAOYSA-N 0.000 claims 2
- 208000028698 Cognitive impairment Diseases 0.000 claims 2
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 208000015114 central nervous system disease Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 208000029364 generalized anxiety disease Diseases 0.000 claims 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- 208000019906 panic disease Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims 1
- -1 2,3-difluorophenyl Chemical group 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- USWSHXCFJJSHDE-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=CC(Cl)=C1Cl USWSHXCFJJSHDE-UHFFFAOYSA-N 0.000 claims 1
- QQMUFVZGYVONBS-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-prop-2-enylpyrrolidin-3-ol Chemical compound C=1C=CC(F)=C(F)C=1C1(O)CCN(CC=C)C1 QQMUFVZGYVONBS-UHFFFAOYSA-N 0.000 claims 1
- CQRPFHDPCOFOIL-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC=CC(C2(F)CNCC2)=C1F CQRPFHDPCOFOIL-UHFFFAOYSA-N 0.000 claims 1
- NVJZWXSTCVALIX-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(F)C=C1F NVJZWXSTCVALIX-UHFFFAOYSA-N 0.000 claims 1
- AYFLLPMVZQVMIM-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(Cl)C(Cl)=C1 AYFLLPMVZQVMIM-UHFFFAOYSA-N 0.000 claims 1
- RZPNURHRNBRHQL-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(F)C(F)=C1 RZPNURHRNBRHQL-UHFFFAOYSA-N 0.000 claims 1
- RAFSLGNAHYYRST-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-propan-2-ylpyrrolidin-3-ol Chemical compound C1N(C(C)C)CCC1(O)C1=CC=C(F)C(F)=C1 RAFSLGNAHYYRST-UHFFFAOYSA-N 0.000 claims 1
- ZJOAAWUEZFVQHP-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC(Cl)=CC(Cl)=C1 ZJOAAWUEZFVQHP-UHFFFAOYSA-N 0.000 claims 1
- MTSVWPYXOZDKAU-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-3-fluoropyrrolidine Chemical compound C=1C(Cl)=CC(Cl)=CC=1C1(F)CCNC1 MTSVWPYXOZDKAU-UHFFFAOYSA-N 0.000 claims 1
- VAYCSAOIQFQZJH-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC(F)=CC(F)=C1 VAYCSAOIQFQZJH-UHFFFAOYSA-N 0.000 claims 1
- PDOGFKRZZSBEGE-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC(F)=CC(C2(F)CNCC2)=C1 PDOGFKRZZSBEGE-UHFFFAOYSA-N 0.000 claims 1
- SSWRIHFVYMUNQR-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(F)C(Cl)=C1 SSWRIHFVYMUNQR-UHFFFAOYSA-N 0.000 claims 1
- UALDFWPLQVYDFB-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(F)C(Cl)=C1 UALDFWPLQVYDFB-UHFFFAOYSA-N 0.000 claims 1
- DRHLAPLUKBFHAQ-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC(F)=CC(Cl)=C1 DRHLAPLUKBFHAQ-UHFFFAOYSA-N 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 208000012239 Developmental disease Diseases 0.000 claims 1
- 208000027534 Emotional disease Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 206010034912 Phobia Diseases 0.000 claims 1
- 208000029560 autism spectrum disease Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 206010008129 cerebral palsy Diseases 0.000 claims 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000010249 dopaminergic function Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 1
- JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical compound OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 claims 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 201000001716 specific phobia Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 0 *C1(CN(*)CC1)c1cc(*)cc(*)c1 Chemical compound *C1(CN(*)CC1)c1cc(*)cc(*)c1 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94199407P | 2007-06-05 | 2007-06-05 | |
| US60/941,994 | 2007-06-05 | ||
| SE0701387-3 | 2007-06-05 | ||
| SE0701387 | 2007-06-05 | ||
| PCT/EP2008/056915 WO2008148801A2 (en) | 2007-06-05 | 2008-06-04 | Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010529081A JP2010529081A (ja) | 2010-08-26 |
| JP2010529081A5 true JP2010529081A5 (cg-RX-API-DMAC7.html) | 2011-07-14 |
| JP5444535B2 JP5444535B2 (ja) | 2014-03-19 |
Family
ID=39743744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510783A Expired - Fee Related JP5444535B2 (ja) | 2007-06-05 | 2008-06-04 | 皮質カテコールアミン作動性神経伝達の調節物質としての新規な二置換フェニルピロリジン |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8188301B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2155671B8 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5444535B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100038295A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101808987A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008258599B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0812740A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2690091A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO6251288A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL202045A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009012787A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ581364A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2471781C2 (cg-RX-API-DMAC7.html) |
| UA (1) | UA98783C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008148801A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200908592B (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100038295A (ko) | 2007-06-05 | 2010-04-14 | 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 | 피질 카테콜아민성 신경 전달의 조정자로서의 이치환된 페닐피롤리딘 |
| US20110257148A1 (en) * | 2008-11-24 | 2011-10-20 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Novel 1-alkyl-3-hydroxy-3-phenylazetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
| CN102224135A (zh) | 2008-11-24 | 2011-10-19 | Nsab神经研究瑞典公司分公司 | 用作皮质儿茶酚胺能神经传递调节剂的新3-苯基-氮杂环丁烷衍生物 |
| EP2367788A1 (en) | 2008-11-24 | 2011-09-28 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission |
| CN102282155B (zh) | 2008-12-02 | 2017-06-09 | 日本波涛生命科学公司 | 磷原子修饰的核酸的合成方法 |
| AR074755A1 (es) * | 2008-12-16 | 2011-02-09 | Astrazeneca Ab | Derivados cuaternarios de piperidina y sus usos |
| BR112012000828A8 (pt) | 2009-07-06 | 2017-10-10 | Ontorii Inc | Novas pró-drogas de ácido nucleico e métodos de uso das mesmas |
| EP2620428B1 (en) | 2010-09-24 | 2019-05-22 | Wave Life Sciences Ltd. | Asymmetric auxiliary group |
| ES2626488T3 (es) | 2011-07-19 | 2017-07-25 | Wave Life Sciences Pte. Ltd. | Procedimientos para la síntesis de ácidos nucleicos funcionalizados |
| ES2862073T3 (es) | 2012-07-13 | 2021-10-06 | Wave Life Sciences Ltd | Grupo auxiliar asimétrico |
| BR112015000723A2 (pt) | 2012-07-13 | 2017-06-27 | Shin Nippon Biomedical Laboratories Ltd | adjuvante de ácido nucléico quiral |
| ES2940887T3 (es) | 2012-07-13 | 2023-05-12 | Wave Life Sciences Ltd | Método de preparación de oligonucleótidos quirales |
| JPWO2015108048A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
| WO2015108047A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
| US10322173B2 (en) | 2014-01-15 | 2019-06-18 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent |
| CN113278617A (zh) | 2014-01-16 | 2021-08-20 | 波涛生命科学有限公司 | 手性设计 |
| EP3297987B1 (en) | 2015-05-20 | 2019-05-15 | Integrative Research Laboratories Sweden AB | Novel azetidine derivatives useful as modulators of cortical cathecolaminergic neurotransmission |
| EP3415499B1 (en) | 2016-02-10 | 2020-05-13 | Sumitomo Chemical Company, Limited | Method for producing 1-methylpyrrolidin-3-ol |
| ES2943252T3 (es) * | 2017-05-19 | 2023-06-12 | Integrative Res Laboratories Sweden Ab | Fumarato de (+)-3-(2,3-difluorofenil)-3-metoxipirrolidina, un proceso para su preparación y sus usos |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2878264A (en) | 1959-03-17 | Substituted amino alcohols | ||
| DE1144279B (de) | 1957-09-26 | 1963-02-28 | Robins Co Inc A H | Verfahren zur Herstellung von 3-Aryl-3-hydroxypyrrolidinen und deren Salzen |
| US3118907A (en) * | 1961-08-14 | 1964-01-21 | Mead Johnson & Co | 3-substituted-3-pyrrolidinols |
| BE704683A (cg-RX-API-DMAC7.html) | 1966-11-07 | 1968-02-15 | ||
| US3635982A (en) | 1969-04-08 | 1972-01-18 | American Home Prod | Amino-substituted-quinoxalinyloxazolidines and -oxazines |
| US5128362A (en) | 1988-01-15 | 1992-07-07 | Abbott Laboratories | 1-aminomethyl-1,2,3,4-tetrahydronaphthalenes |
| DE3802175A1 (de) | 1988-01-26 | 1989-08-03 | Hoechst Ag | N-phenylbenzamide und n-phenylbenzamidoxime, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schaedlingsbekaempfungsmittel |
| DE3835291A1 (de) * | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
| US5444083A (en) * | 1989-02-03 | 1995-08-22 | Eisai Co., Ltd. | Pyrrolidine compound and pharmaceutical use |
| ES2157204T3 (es) * | 1991-04-17 | 2001-08-16 | Upjohn Co | Derivados de (s)-3-fenilpiperidina sustituidos, su preparacion y uso como antagonistas de autorreceptores de dopamina. |
| EP0586229A1 (en) * | 1992-09-01 | 1994-03-09 | Zeneca Limited | 3-Hydroxy-3-(subst-akyl)-pyrrolidines as 5-lipoxygenase inhibitors |
| US5665754A (en) * | 1993-09-20 | 1997-09-09 | Glaxo Wellcome Inc. | Substituted pyrrolidines |
| WO1997024325A1 (en) | 1995-12-28 | 1997-07-10 | Takeda Chemical Industries, Ltd. | DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS |
| HUP0102622A3 (en) | 1998-07-20 | 2002-12-28 | Merck Patent Gmbh | Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them |
| US20020169155A1 (en) | 1998-09-04 | 2002-11-14 | Millennium Pharmaceuticals, Inc. | Chemokine receptor anagonists and methods of use therefor |
| US7271176B2 (en) | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
| DE19840611A1 (de) * | 1998-09-05 | 2000-03-09 | Klaus Wanner | GABA-uptake-Inhibitoren mit Pyrrolidinstruktur |
| WO2000070417A1 (en) | 1999-05-17 | 2000-11-23 | The Foxboro Company | Process control configuration system with parameterized objects |
| ECSP003637A (es) | 1999-08-31 | 2002-03-25 | Agouron Pharma | Inhibidores triciclicos de poli (adp-ribosa) polimerasas |
| SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
| US7547693B2 (en) | 2003-09-22 | 2009-06-16 | Banyu Pharmaceutical Co. Ltd. | Piperidine derivative |
| SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
| US7700587B2 (en) | 2004-09-07 | 2010-04-20 | Florida A&M University | Haloperidol analogs |
| US7598279B2 (en) | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| JP2008540395A (ja) | 2005-05-03 | 2008-11-20 | ファイザー・インク | アミドレソルシノール化合物 |
| WO2007053145A1 (en) | 2005-11-04 | 2007-05-10 | Florida A & M University | Haloperidol analogs |
| EP1966164B1 (en) | 2005-12-21 | 2013-03-06 | Janssen Pharmaceutica N.V. | Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| KR20100038295A (ko) | 2007-06-05 | 2010-04-14 | 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 | 피질 카테콜아민성 신경 전달의 조정자로서의 이치환된 페닐피롤리딘 |
| US20100197760A1 (en) | 2007-06-05 | 2010-08-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
-
2008
- 2008-06-04 KR KR1020097025393A patent/KR20100038295A/ko not_active Withdrawn
- 2008-06-04 CN CN200880018820A patent/CN101808987A/zh active Pending
- 2008-06-04 CA CA2690091A patent/CA2690091A1/en not_active Abandoned
- 2008-06-04 WO PCT/EP2008/056915 patent/WO2008148801A2/en not_active Ceased
- 2008-06-04 NZ NZ581364A patent/NZ581364A/en not_active IP Right Cessation
- 2008-06-04 MX MX2009012787A patent/MX2009012787A/es active IP Right Grant
- 2008-06-04 UA UAA200911475A patent/UA98783C2/ru unknown
- 2008-06-04 RU RU2009143104/04A patent/RU2471781C2/ru not_active IP Right Cessation
- 2008-06-04 AU AU2008258599A patent/AU2008258599B2/en not_active Expired - Fee Related
- 2008-06-04 EP EP08760496.3A patent/EP2155671B8/en not_active Not-in-force
- 2008-06-04 BR BRPI0812740A patent/BRPI0812740A2/pt not_active IP Right Cessation
- 2008-06-04 JP JP2010510783A patent/JP5444535B2/ja not_active Expired - Fee Related
- 2008-06-04 US US12/663,223 patent/US8188301B2/en not_active Expired - Fee Related
-
2009
- 2009-11-11 IL IL202045A patent/IL202045A0/en unknown
- 2009-12-03 ZA ZA2009/08592A patent/ZA200908592B/en unknown
- 2009-12-18 CO CO09145364A patent/CO6251288A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010529081A5 (cg-RX-API-DMAC7.html) | ||
| RU2471781C2 (ru) | Новые двузамещенные фенилпирролидины в качестве модуляторов кортикальной катехоламинергической нейротрансмиссии | |
| RU2010119560A (ru) | Замещенные n-фенилбипирролидинкарбоксамиды и их терапевтическое применение | |
| TWI727172B (zh) | 新穎聯苯化合物或其鹽 | |
| JP5947465B2 (ja) | Ｃｎｓ活性剤としてのベンズイミダゾール類 | |
| RU2010119528A (ru) | Замещенные n-фенилбипирролидинкарбоксамиды и их применение в лечебных целях | |
| RU2009103307A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| JP2011500696A5 (cg-RX-API-DMAC7.html) | ||
| MX375169B (es) | Derivados de indolin-2-ona o pirrolo-piridin-2-ona. | |
| RU2010119554A (ru) | Замещенные n-фенил-бипирролидинмочевины и их терапевтическое применение | |
| WO2015107053A1 (en) | N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders | |
| JP2020500215A5 (cg-RX-API-DMAC7.html) | ||
| JP2019535825A5 (cg-RX-API-DMAC7.html) | ||
| JP2018516906A5 (cg-RX-API-DMAC7.html) | ||
| CN105829300A (zh) | 作为pde1抑制剂的喹唑啉-thf-胺 | |
| JP2002525280A5 (cg-RX-API-DMAC7.html) | ||
| AU2017353313A1 (en) | (1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors | |
| TWI664178B (zh) | 作爲ｐｄｅ１抑制劑之鹵化喹唑啉－ｔｈｆ－胺 | |
| CA2544213A1 (en) | Imidazo[1,2-a]pyridine anxiolytics | |
| RU2011127382A (ru) | Замещенные тетрагидропиранспиропирролидинон и тетрагидропиранспиропиперидинон, способ их получения и применение в лечебных целях | |
| CN106414459B (zh) | 作为pde1抑制剂的六氢呋喃并吡咯 | |
| JP6007339B2 (ja) | イミダゾピリジン誘導体 | |
| JP2010529080A5 (cg-RX-API-DMAC7.html) | ||
| NZ548926A (en) | Inhibitors of TGF-R signaling for treatment of CNS disorders | |
| JP2011510991A5 (cg-RX-API-DMAC7.html) |